Search
for
Sort by
Research 151–180 of 1000+
- Confluent and Reticulated Papillomatosis Associated with Polycystic Ovarian Syndrome
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient
- 3D Microtumors Representing Ovarian Cancer Minimal Residual Disease Respond to the Fatty Acid Oxidation Inhibitor Perhexiline
- A review on PCOS: Its causes, symptoms, pathogenesis and management
- Prevalence, Symptomatology and Herbal Management of Polycystic Ovarian Syndrome
- NAD⁺ Biology in Ageing and Chronic Disease: Mechanisms and Evidence across Skin, Fertility, Osteoarthritis, Hearing and Vision Loss, Gut Health, Cardiovascular–Hepatic Metabolism, Neurological Disorders, and Muscle
- DHEA and TNF-α: Key Factors in Managing Polycystic Ovary Syndrome in Iraqi Females
- Estimation of Dehydroepiandrosterone (DHEA) and Tumor Necrosis Factor–Alpha (TNF-α) Levels Women Diagnosed with Polycystic Syndrome
- A brief report on PCOS: and its inducing model
- Lifestyle changes and Nutrition in Polycystic Ovarian Disorder: A Holistic Review
- Evaluation of Some Hormones Total Antioxidant Capacity and Malondialdehyde Levels in Polycystic Ovarian Syndrome Women attending the gynecology Clinic at Nnewi
- A review on polyherbal and supplemental approach to treat Polycystic Ovarian Syndrome
- Rare and Underappreciated Causes of Polycystic Ovarian Syndrome
- Androgenic disorders
- Hyperandrogenism in polycystic ovarian syndrome and role of CYP gene variants: a review
- Radiomics and radiogenomics in ovarian cancer: a review with a focus on ultrasound applications
- ApoBDs: a paradigm shift from cellular debris to therapeutic vehicles
- Progress in research on the effects of Platelet-Rich Plasma (PRP) ovarian injection on early ovarian reserve dysfunction and premature ovarian insufficiency
- Male polycystic ovarian syndrome phenotype: a meta-analysis of endocrine-metabolic dysregulation in fathers and brothers of PCOS-affected women
- Functional Ingredient Mapping in PCOS Formulations: Hormonal Excess
- ST14 interacts with TMEFF1 and is a predictor of poor prognosis in ovarian cancer
- S100A4/Nonmuscle Myosin IIA/p53 Axis Contributes to Aggressive Features in Ovarian High-Grade Serous Carcinoma
- Emerging Roles for Ion Channels in Ovarian Cancer: Pathomechanisms and Pharmacological Treatment
- Identification of functional circRNAs regulating ovarian follicle development in goats
- Cell Proteomic Footprinting: Advances in the Quality of Cellular and Cell-Derived Cancer Vaccines
- The Administration of Ocoxin Increases the Quality of Life of Patients with Advanced Epithelial or Metastatic Ovarian Cancer Undergoing Neoadjuvant Chemotherapy
- From Follicle Cell Differentiation and Structure to Chorion Biogenesis in Insects: Cellular Mechanisms, Gene Regulation, Biochemical Composition and Structural Diversity
- Novel anti-Mullerian hormone receptor 2 binding peptide prevents chemotherapy-related ovarian follicle loss in a mouse model
- Modern Polycystic Ovary Syndrome (PCOS) Management: Intelligent Drug Delivery and Metabolic Reprogramming for Ovarian Restoration and Fertility Optimization
- FETAL METABOLIC PROGRAMMING IN THE ETIOLOGY OF POLYCYSTIC OVARIAN SYNDROME